Biohaven Ltd.

BHVN

Exchange: NYSE
Industry: Pharmaceutical Preparations
SEC CIK: 0001935979

SEC filings (opens in a new tab)

No open-market purchases or sales by Biohaven Ltd. insiders were filed in the last 90 days; 299 institutions reported holding it in 13F filings for Q2 2026, worth $2.13B in total; no superinvestor holds it.

Key figures

Market capClose on Nov 10, 2026: $2.28B
Insider buysOpen market, last 90 days: 0
Insider sellsOpen market, last 90 days: 0
13F holdersQ2 2026, +21 vs. previous quarter: 299
13F valueReported value at the end of Q2 2026: $2.13B
Superinvestors holdingAt the end of Q2 2026: 0

Price chart

Chart by TradingView (opens in a new tab)

Financials

See financial statements

From SEC filings, in USD.

Revenue, FY2025: –; No comparable prior period
Net income, FY2025: -$738.8M; No comparable prior period
Free cash flow, FY2025: -$610.2M; No comparable prior period
Revenue, Q3 FY2026: –; No comparable prior period

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest: 15.0M; Shares sold short
Change: −2.89M; −16.1% vs. previous
Days to cover: 2.94; At average daily volume

Superinvestors holding BHVN, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding BHVN at the end of Q2 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by Biohaven Ltd. insiders from Form 4, newest first.

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
Mar 9, 2026 (view filing)	Mar 4, 2025	370 days	Childs John WDirector	PPurchase	+28.4K	$30.43	+$864.2K	+1.2%2.32M after	Amended
Nov 18, 2025 (view filing)	Nov 17	1 day	Clark George C.VP, Chief Accounting Officer	PPurchase	+17.0K	$8.52	+$144.8K	+566.7%20.0K after
Nov 17, 2025 (view filing)	Nov 13	4 days	Bailey GregoryDirector	PPurchase	+400.0K	$7.50	+$3.00M	+24.7%2.02M after
Nov 17, 2025 (view filing)	Nov 13	4 days	Coric VladChief Executive Officer	PPurchase	+666.7K	$7.50	+$5.00M	+902.4%740.5K after	2 lots
Nov 17, 2025 (view filing)	Nov 13	4 days	Childs John WDirector	PPurchase	+3.33M	$7.50	+$25.0M	+143.6%5.65M after
Mar 5, 2025 (view filing)	Apr 22, 2024	317 days	Childs John WDirector	PPurchase	+73.2K	$41.00	+$3.00M	New position73.2K after	Amended
Mar 5, 2025 (view filing)	Mar 4	1 day	Childs John WDirector	PPurchase	+7.70K	$30.73	+$236.6K	+43.8%25.3K after	From original3 lots
Dec 31, 2024 (view filing)	Dec 30	1 day	Childs John WDirector	PPurchase	+29.0K	$35.94	+$1.04M	+1.2%2.37M after
Oct 3, 2024 (view filing)	Oct 2	1 day	Childs John WDirector	PPurchase	+21.1K	$47.50	+$1.00M	New position21.1K after
Oct 3, 2024 (view filing)	Oct 2	1 day	Coric VladChief Executive Officer	PPurchase	+21.1K	$47.50	+$1.00M	+2.5%861.9K after

Top 10 13F holders, Q2 2026

See all 299 holders

The largest institutional positions in Biohaven Ltd. at the end of Q2 2026; share changes are against Q1 2026.

Institutions holding BHVN in Q2 2026
Institution	Shares	Value	% of portfolio	Change in shares	Action
BlackRock, Inc.	13,210,585	$196.6M	0.00%	+1,988,178+17.7%	Added
Suvretta Capital Management, LLC	10,286,937	$153.1M	3.22%	00.0%	Unchanged
Stifel Financial Corp	9,941,165	$147.9M	0.12%	+2800.0%	Added
Jupiter Topco LLC	8,584,675	$127.9M	0.05%	+8,584,675	New
Woodline Partners LP	7,660,280	$114.0M	0.35%	+7,359,891+2,450.1%	Added
State Street Corp	6,947,034	$103.4M	0.00%	+328,231+5.0%	Added
Infinitum Asset Management, LLC	6,250,000	$93.0M	9.46%	00.0%	Unchanged
D. E. Shaw & Co., Inc.	4,190,195	$62.4M	0.04%	+1,343,002+47.2%	Added
AQR Capital Management LLC	4,150,616	$61.8M	0.02%	+2,175,100+110.1%	Added
Geode Capital Management, LLC	3,323,190	$49.5M	0.00%	+555,427+20.1%	Added

Holders of 5% or more of BHVN

See all 3 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Biohaven Ltd..

Largest holders of BHVN from 13D and 13G filings
Holder	Latest form	Stake	Change	First filed	Latest filing	Filing
Suvretta Capital Management, LLC	13G/A	7.80%10.3M shares	–	Nov 2, 20224 filings	Feb 13, 2026	SEC
Janus Henderson Group PLC	13G/A	5.70%8.58M shares	−6.00 ppfrom 11.70%	Feb 13, 202310 filings	Jul 8, 2026	SEC
Woodline Partners LP	13G	5.10%7.66M shares	New	Aug 14, 20261 filing	Aug 14, 2026	SEC